Tutkimusnäyttö eri
syöpälajeissa
Munasarjasyöpä
Schad F, Thronicke A. Safety of Combined Targeted and Helixor® Viscum album L. Therapy in Breast and Gynecological Cancer Patients, a Real-World Data Study. International Journal of Environmental Research and Public Health 2023;20:2565. DOI: https://doi.org/10.3390/ijerph 20032565.
Ostermann T, Appelbaum S, Poier D, Boehm K, Raak C and Büssing A. A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings. Complement Med Res. 2020 Jan 10:1-12. doi: 10.1159/000505202.
Kts. lisätietoja julkaisijan sivuilta
Werthmann PG, Kempenich R, Kienle GS. Long-term tumor-free survival in a patient with stage IV epithelial ovarian cancer undergoing high-dose chemotherapy and viscum album extract treatment: A case report. Perm J 2019;23:18-025. DOI: https://doi.org/10.7812/TPP/18-025
Hwang WY, Kang MH, Lee SK, Yeom JS, Jung MH. Prolonged stabilization of platinum-refractory ovarian cancer in a single patient undergoing long-term mistletoe extract treatment: Case report. Medicine 2019; 98 (8). Article ID e14536. 4 pp. DOI: 10.1097/MD.0000000000014536.
Drozdoff L, Klein E, Kalder M, Brambs C, Kiechle M, Paepke D. Potential interactions of biologically based complementary medicine in gynecological oncology. Integrative Cancer Therapies 2019: 18(10) pp. DOI: 10.1177/1534735419846392.
Grossarth-Maticek R and Ziegler R. Prospective controlled cohort studies on long-term therapy of ovarian cancer patients with mistletoe (Viscum album L.) extracts Iscador. Arzneimittelforschung 2007;57(10):665–678.
Piao B K, Wang Y X, Xie G R, Mannsmann U, Matthes H, Beuth J and Lin H S. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Research 2004;24:303-310
Leroi R, Hajto T. Die Iscadortherapie beim Ovarialkarzinom. Krebsgeschehen. 1982;14(2): 38–44.
Majewski A, Bentele W. Uber Zusatzbehandlung beim weiblichen Genitalkarzinom. Zentralbl Gynakol. 1963; 85(20): 696–700.